Alerts & Updates 8th Jun 2023

Regulatory Blindspot and Contradictions: Sale, Manufacturing and Price Regulation of India’s Medical Devices market

Authors

Ashishchandra Rao Partner | Mumbai
Ashna Contractor Senior Associate | Mumbai

Latest Thought Leadership

News & Media 25th Jun 2024

Misleading Ads: Ambiguous Self-Declaration Rules Leave Advertisers in Compliance Limbo

Read More
News & Media 25th Jun 2024

Budget 2024 expectations: Will the government increase Section 80C limit

Read More
News & Media 25th Jun 2024

MC Exclusive: FSSAI calls for strict compliance of food safety protocols after alarming contamination reports

Read More
News & Media 25th Jun 2024

Budget 2024: AIFs seek tax parity with FPIs

Read More

The medical devices sector in India is growing in size and in importance. It’s evolving regulatory regime is one to watch.

While medical devices long fell into a regulatory blindspot, recent innovations, technological developments, and the COVID-19 pandemic have emphasized the sector’s prominence and potential. However, new regulatory developments in the medical devices sector have presented some contradictions. On the one hand, initiatives such as the Production Linked Incentives Scheme for Medical Devices and the National Medical Devices Policy 2023 aim to encourage medical device manufacturing and research within the country. On the other hand, the NPPA’s price caps and increased regulatory authority over medical devices may discourage domestic innovation and manufacturing.

Against this backdrop, Ashish Rao, Partner, and Ashna Contractor, Senior Associate, Economic Laws Practice (ELP) have co-authored an article titled Regulatory Blindspot and Contradictions: Sale, Manufacturing and Price Regulation of India’s Medical Devices market published by Mondaq. The article examines these latest developments and provides an introductory overview of the medical devices regulatory regime.

For further details, read the article here: Click here